Schedule 13D ownership disclosure
Opus Genetics, Inc.
Security class unavailable · CUSIP: 67577R102
Event date: 2024-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-246646
- Form type
- SC 13D
- Filer
- Foundation Fighting Blindness Retinal Degeneration Fund
- CIK
- CIK 2042266
- Filed
- Oct 29, 2024
- Reporting period
- Oct 22, 2024
- Description
- Schedule 13D beneficial ownership